Summary
A DRUG company has lost its appeal to get a Tynesidedeveloped treatment extended to lung cancer patients.
The National Institute for Health and Clinical Excellence (Nice) last month accepted Alimta for treating people with asbestos- related cancer on the NHS.See the full content of this document
Extract
Cancer Drug Loss
Following an a...
See the full content of this document
Sponsored links
